Inhibition of mircoRNA-34a enhances survival of human bone marrow mesenchymal stromal/stem cells under oxidative stress

Medical Science Monitor

Volumn 24, Issue , 2018, Pages 264-271

  Liu, Yang ^a,b,c,d   Zhang, Xiaohu ^c,d   Chen, Jie ^b   Li, Tingyu ^b  

^a SICHUAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Cell survival; Mesenchymal stromal cells; MicroRNAs; Oxidative stress

Indexed keywords

HYDROGEN PEROXIDE; KI 67 ANTIGEN; MICRORNA 34A; PROTEIN BCL 2; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICRORNA; MIRN34 MICRORNA, HUMAN;

ARTICLE; BMSC CELL LINE; CELL DEATH; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL SURVIVAL; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OXIDATIVE STRESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; DRUG EFFECT; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

APOPTOSIS; CELL SURVIVAL; HUMANS; HYDROGEN PEROXIDE; INHIBITOR OF APOPTOSIS PROTEINS; KI-67 ANTIGEN; MESENCHYMAL STROMAL CELLS; MICRORNAS; OXIDATIVE STRESS;

EID: 85040934930     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.904618     Document Type: Article

References (39)

1. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 1997; 276: 71-74
2. Pittenger MF, Mackay AM, Beck SC et al: Multilineage potential of adult human mesenchymal stem cells. Science, 1999; 284: 143-47
3. Jiang Y, Jahagirdar BN, Reinhardt RL et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002; 418: 41-49
4. Joyce N, Annett G, Wirthlin L et al: Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med, 2010; 5: 933-46
5. Liu Y, Jiang X, Zhang X et al: Dedifferentiation-reprogrammed mesenchymal stem cells with improved therapeutic potential. Stem Cells, 2011; 29: 2077-89
6. Wen Z, Zheng S, Zhou C et al: Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med, 2011; 15: 1032-43
7. Wen Z, Zheng S, Zhou C et al: Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators. J Cell Mol Med, 2012; 16: 657-71
8. Ning H, Yang F, Jiang M et al: The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia, 2008; 22: 593-99
9. Kuriyan AE, Albini TA, Townsend JH et al: Vision loss after intravitreal injection of autologous “stem cells” for AMD. New Engl J Med, 2017; 376: 1047-53
10. Ankrum J, Karp JM: Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med, 2010; 16: 203-9
11. Yagi H, Soto-Gutierrez A, Parekkadan B et al: Mesenchymal stem cells:Mechanisms of immunomodulation and homing. Cell Transplant, 2010; 19: 667-79
12. Song H, Kwon K, Lim S et al: Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells, 2005; 19: 402-7
13. Li W, Ma N, Ong L-L et al: Bcl-2 Engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 2007; 25: 2118-27
14. Zeng W, Xiao J, Zheng G et al: Antioxidant treatment enhances human mesenchymal stem cell anti-stress ability and therapeutic efficacy in an acute liver failure model. Sci Rep, 2015; 5: 11100
15. Mohammadzadeh M, Halabian R, Gharehbaghian A et al: Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity. Cell Stress Chaperones, 2012; 17: 553-65
16. Trouche E, Mias C, Seguelas MH et al: Characterization of monoamine oxidases in mesenchymal stem cells: Role in hydrogen peroxide generation and serotonin-dependent apoptosis. Stem Cells Dev, 2010; 19: 1571-78
17. Tarasov V, Jung P, Verdoodt B et al: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 2007; 6: 1586-93
18. Liao JM, Cao B, Zhou X et al: New insights into p53 functions through its target microRNAs. J Mol Cell Biol, 2014; 6: 206-13
19. Macip S, Igarashi M, Berggren P et al: Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol, 2003; 23: 8576-85
20. Karawajew L, Rhein P, Czerwony G et al: Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood, 2005; 105: 4767-75
21. Lv B, Li F, Fang J et al. Hypoxia inducible factor 1alpha promotes survival of mesenchymal stem cells under hypoxia. Am J Transl Res, 2017; 9: 1521-29
22. Zhang JM, Feng FE, Wang QM et al. Platelet-derived growth factor-BB protects mesenchymal stem cells (MSCs) derived from immune thrombocytopenia patients against apoptosis and senescence and maintains MSCmediated immunosuppression. Stem Cells Transl Med, 2016; 5: 1631-43
23. Raver-Shapira N, Marciano E, Meiri E et al: Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell, 2007; 26: 731-43
24. Aranha MM, Santos DM, Sola S et al: miR-34a regulates mouse neural stem cell differentiation. PLoS One, 2011; 6: e21396
25. Konat GW: H2O2-induced higher order chromatin degradation: A novel mechanism of oxidative genotoxicity. J Biosci, 2003; 28: 57-60
26. Valks DM, Kemp TJ, Clerk A: Regulation of Bcl-xL expression by H2O2 in cardiac myocytes. J Biol Chem, 2003; 278: 25542-47
27. Mohammadian M, Shamsasenjan K, Lotfi Nezhad P et al: Mesenchymal stem cells: New aspect in cell-based regenerative therapy. Adv Pharm Bull, 2013; 3: 433-37
28. Wei X, Yang X, Han ZP et al. Mesenchymal stem cells: A new trend for cell therapy. Acta Pharmacol Sin, 2013; 34: 747-54
29. Diez-Tejedor E, Gutierrez-Fernandez M, Martinez-Sanchez P et al: Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: A safety assessment: A phase II randomized, doubleblind, placebo-controlled, single-center, pilot clinical trial. J Stroke Cerebrovasc Dis, 2014; 23(10): 2694-700
30. Humphreys BD, Bonventre JV: Mesenchymal stem cells in acute kidney injury. Annu Rev Med, 2008; 59: 311-25
31. Levraut J, Iwase H, Shao ZH et al: Cell death during ischemia: Relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol, 2003; 284: H549-58
32. Carpi A, Menabo R, Kaludercic N et al. The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim Biophys Acta, 2009; 1787: 774-80
33. Chen T, Wong YS: Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation. Cell Mol Life Sci, 2008; 65: 2763-75
34. Nguyen Ngoc TD, Son YO, Lim SS et al: Sodium fluoride induces apoptosis in mouse embryonic stem cells through ROS-dependent and caspase- and JNK-mediated pathways. Toxicol Appl Pharmacol, 2012; 259: 329-37
35. Yuan L, Wei S, Wang J et al: Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells. J Agric Food Chem, 2014; 62: 5390-400
36. Lee S, Choi E, Cha M-J et al: Cell adhesion and long-term survival of transplanted mesenchymal stem cells: A prerequisite for cell therapy. Oxid Med Cell Longev, 2015; 2015: 9
37. Li H, Rokavec M, Jiang L et al. Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells. Gastroenterology, 2017 [Epub ahead of print]
38. Reed JC: Bcl-2 family proteins. Oncogene, 1998; 17: 3225-36
39. Chen H, Wang J, Hu B et al: MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2. Mol Cell Biochem, 2015; 406: 21-30